Cebadores and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using inmunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: Report of the BIOMED-1 Concerted: Action Investigation of minimal residual disease in acute leukemia
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.